Furthermore, the TNFRSF1A expression prolife of various tumors from the GEPIA2 illustrated that TNFRSF1A was significantly overexpressed in four kinds of tumors compared with the corresponding normal samples, including GBM, LAML (acute myeloid leukemia), LGG and PAAD (pancreatic adenocarcinoma) (Figure 3B). This evidence concerns the gene TNFRSF1A and glioblastoma.